Gender and haemato-oncology: Aspects of pharmacokinetics and pharmacodynamics | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.12.2011 | Short review

Gender and haemato-oncology: Aspects of pharmacokinetics and pharmacodynamics

verfasst von: R. M. Mader, M. Fiegl

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Gender differences in quality of life in patients with haematological malignancies

Nächster Artikel Cancer in the elderly and gender aspects – situation in Tyrol

Titel: Gender and haemato-oncology: Aspects of pharmacokinetics and pharmacodynamics
verfasst von: R. M. Mader
M. Fiegl
Publikationsdatum: 01.12.2011
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 4/2011
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-011-0298-8

Weitere Artikel der Ausgabe 4/2011

Gender and oncology: Pathological observations

Short review

Preclinical research in oncology: Gender aspects

Short review

The role of radiochemotherapy in the multimodal treatment of pancreatic ductal adenocarcinoma: Standard procedure or individual decision?

Short review

Treatment of invasive aspergillosis in cancer patients

Short review

Epidermal growth factor receptor-targeted treatment strategies in advanced pancreatic cancer: Is K-RAS mutational testing ready for prime time?

Controversy

A histology-based algorithm in the molecular diagnosis of mutations of the epidermal growth factor receptor (EGFR)–in non-small-cell lung cancer (NSCLC)*

Consensus report